Field Trip Psychedelics has just announced a letter of intent to go public via RTO.
Psychedelics
ATAI launches IntroSpect Digital Therapeutics, Appoints veteran software engineer David Keene as CEO
ATAI is adding a digital therapeutics division to its R&D platform.
Champignon Provides Corporate Update, Announces Name Change, Rebranding and Planned Spin Out
Champignon Brands is proposing changing its corporate name to Apotheosis Scientific Ltd, and announces a planned spin-off its consumer packaged goods (CPG) division.
Red Light Holland Announces The Closing of Second Tranche of Private Placement
With the closing of its second tranche, Red Light Holland has now raised $3,830,529 in its current private placement.
Canadians More Receptive To Use Of Psilocybin For The Terminally Ill: New Poll
Canadians are rapidly warming up to the idea of using psilocybin to reduce distress among the terminally ill.
Eleusis Looks For Alzheimer’s Breakthrough With Micro-Dosed LSD
Eleusis Therapeutics is a private psychedelics company that is turning a lot of heads with its research on micro-doses of LSD as a treatment for Alzheimer's.
MindMed And Eleusis Lead The Way In Psychedelics Micro-Dosing Research
Given that psychedelics micro-dosing has several commercial advantages, here are two companies that investors should look at.
Clarmin Explorations Inc. Enters Into Amalgamation Agreement for Reverse Takeover With Cybin Corp.
Cybin Corp will become the latest psychedelics company to go public, via RTO.
Psychedelics Investing 101: Basic Investing Tips
Psychedelic drugs are an emerging sector with exciting investment potential. Here are some tips on beginning your due diligence.
Empower to Open Wellness Clinic in Vancouver, Provides Updates on Its Psychedlics Division Dosed Wellness
Empower's new wellness clinic in Vancouver will support development of its psychedelics division.
Numinus Positioned To Be Significant Player In Psilocybin R&D
Numinus Wellness Inc. has assembled the licensing and personnel to be a significant player in psilocybin-based drug research.
Havn Life Sciences Inc. Announces Launch & Filing of Preliminary Prospectus
New psychedelics company specializing in psilocybin-based medical research has filed a prospectus.
MindMed Developing IP For Personalized Psychedelic Assisted Therapies
MindMed files patent applications for technologies to screen and optimize dosing of MDMA and LSD.
Why Psychedelics Micro-Dosing Applications Have The Inside Track On Commercialization
Psychedelics micro-dosing offers several key advantages over psychedelic drug applications centered around heavier dosages.
Top Canadian Entrepreneur Michael Forbes Joins Board of Directors of PharmaDrug Inc.
PharmaDrug adds depth to its board with new Director who has a wealth of healthcare and addiction-therapy experience.